title: Tracheoesophageal fistula secondary to chemotherapy for malignant B-cell lymphoma of the thyroid: successful surgical treatment with jejunal interposition and mesenteric patch.
abstract: We report a case of tracheoesophageal fistula (TEF) secondary to chemotherapy for primary thyroid lymphoma. A 65-year-old man with a short history of a rapidly enlarging neck mass was diagnosed as having thyroid lymphoma of diffuse, large B-cell type. The TEF occurred during the first course of chemotherapy including cyclophosphamide, doxorubicin, vincristine and prednisolone. After placing a feeding gastrostomy without oral intake, eight cycles of chemotherapy were completed and complete remission was achieved. Although the cervical mass disappeared, TEF and esophageal stenosis persisted. Total thyroidectomy and resection of the stenotic cervical esophagus were carried out followed by interposition of the revascularized jejunum and its mesenteric patch to cover the TEF. This seems to be the first report of a TEF caused by chemotherapy for primary thyroid B-cell lymphoma. A variety of treatments for TEF including simple closure, tracheal resection, colonic bypass and muscle flap have been reported with low success rates. Our procedure using a jejunal mesenteric patch seems to be unique and may be a new treatment strategy for TEF.
authors.affiliation: Department of Surgery Jichi Medical School, Minami-Kawachi, Tochigi, Japan. hosoyo@ichi.ac.jp
authors.forename: Y
authors.initials: Y
authors.lastname: Hosoya
authors.forename: T
authors.initials: T
authors.lastname: Yokoyama
authors.forename: W
authors.initials: W
authors.lastname: Arai
authors.forename: M
authors.initials: M
authors.lastname: Hyodo
authors.forename: H
authors.initials: H
authors.lastname: Nishino
authors.forename: Y
authors.initials: Y
authors.lastname: Sugawara
authors.forename: Y
authors.initials: Y
authors.lastname: Yasuda
authors.forename: H
authors.initials: H
authors.lastname: Nagai
mesh_terms: D000368:Aged; D000714:Anastomosis, Surgical; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004940:Esophageal Stenosis / Q000209:etiology / Q000601:surgery; D004946:Esophagostomy; D006801:Humans; D007582:Jejunostomy; D007583:Jejunum / Q000098:blood supply / Q000601:surgery*; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D008297:Male; D008643:Mesentery / Q000601:surgery*; D011239:Prednisolone / Q000008:administration & dosage; D013964:Thyroid Neoplasms / Q000188:drug therapy*; D013965:Thyroidectomy; D014138:Tracheoesophageal Fistula / Q000139:chemically induced* / Q000601:surgery*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone